Studies have failed to provide a slam-dunk for digital mammography over traditional film x-rays, according to a recent technology assessment report from the ECRI group.
Studies have failed to provide a slam-dunk for digital mammography over traditional film x-rays, according to a recent technology assessment report from the ECRI group.
ECRI, a nonprofit health services research agency, found that digital mammography's ability to detect breast cancer provides no significant improvement over film mammography.
The report reviewed three previously published screening trials that compared the two technologies: a study by Lewin et al published in the September 2002 issue of the American Journal of Roentgenology and the Oslo I and Oslo II screening trials.
While current research indicates that digital mammography may reduce recall rates as well as follow-up procedures, more evidence is needed to confirm these benefits, the ECRI report said.
Mammographers should wait for the results of the ACRIN trial before jumping into a digital purchase, said Dr. Etta Pisano, chief of breast imaging at the University of North Carolina and principal investigator for the American College of Radiology Imaging Network protocol 6652 trial.
The Digital Mammographic Imaging Screening Trial is the most recent study to compare digital and screen-film mammography. It was not included in the ECRI report. Results will be presented in September at the ACRIN meeting in Washington, DC.
Study Says Contrast-Enhanced Mammography Offers Comparable Breast Cancer Detection to MRI
November 15th 2023In findings from an enriched cohort of asymptomatic patients with screening-detected abnormalities, researchers found that contrast-enhanced mammography (CEM) was superior to conventional mammography and offered equivalent detection of breast cancer in comparison to breast MRI and abbreviated breast MRI.
What a New Review Reveals About Mammography-Based AI and Breast Cancer Risk Assessment
November 9th 2023Mammography-based artificial intelligence (AI) models demonstrated an 11 percent higher median AUC for predicting breast cancer than traditional clinical risk factors, according to a new systematic review of 16 retrospective studies.
Mammography News: FDA Clears AI Software for Breast Arterial Calcification Detection
October 17th 2023Utilized in conjunction with screening digital mammography or digital breast tomosynthesis (DBT), the artificial intelligence (AI)-powered software cmAngio may help detect and localize breast arterial calcification (BAC), an incidental finding that has been linked to an elevated risk for heart disease and stroke.